Results
Products & Solutions
Learn More
Tianshu Pharmaceutical
To become an outstanding global supplier of APIs and advanced intermediates, as well as a comprehensive solution service provider

Nanjing Vcare Subsidiary Manufacturing Base

Hubei Tianshu Pharmaceutical Co., Ltd. was jointly funded and established in 2022 by Yicheng Tianshu Textile and Vcare Pharmatech. It is located in Jingxi Huagong Industrial Park Yicheng, a provincial-level chemical industrial park in Hubei Province, with a total area of 150,000 m².

Covers an area of 150,000 m²
2 production workshops
Production capacity 255 m³
3 planning workshops
Planned production capacity 350 m³
R&D and Innovation

Tianshu Pharmaceutical adheres to innovation-driven development, with differentiated technologies as its core, to realize the industrialized production of pharmaceuticals featuring high technical barriers and continuous multi-step complex processes. Meanwhile, it actively explores more green, safe and intelligent advanced engineering technologies in the biopharmaceutical field, such as continuous flow, micro-packed bed, metal catalysis and bio-enzyme catalysis, so as to continuously provide customers with more efficient, high-quality and cost-effective products and services.

Learn More
  • Continuous Flow Engineering Technology Platform

    Continuous flow reaction technology is committed to providing solutions, which are more safe, stable, efficient and precise, compared to traditional hazardous and complex production process.

  • Biological Enzyme Engineering Technology Platform

    Targeted breakthrough in the limitations of traditional synthesis methods to provide milder, more selective, and more chiral pure technical solutions.

  • Chiral Drugs Synthesis and Analysis Technology Platform

    Based on effective route design and strong process optimization capabilities, fully solve the problems of chiral isomer impurities of drugs with similar physicochemical properties caused by similar structures are solved from the source.

  • Crystal Form & Salt Form Screening Technology Platform

    The technology platform has advanced crystal and salt form screening and development strategies, which can quickly and effectively solve technical problems such as difficult crystallization, poor physical and chemical properties, and complex polymorphism.

  • Photochemical Technology Platform

    "Using light as a reagent", it is energy-saving, green and environmentally friendly, easy to control, highly selective, environmentally friendly and can be applied to a variety of reactions.

ESG

Tianshu Pharmaceutical adheres to the EHS (Environment, Health, Safety) work policy of "abiding by laws and regulations, implementing scientific management, engaging full staff participation, prioritizing prevention, conducting process supervision, and pursuing continuous improvement". The company proactively undertakes environmental responsibilities, insists on green innovation, applies energy-saving and emission-reduction technologies, and commits to carrying out comprehensive environmental protection actions in addressing climate change, resource management, and pollutant prevention and control. It also strives to prevent and reduce accidents, diseases, and environmental pollution in the workplace, protect employees' health and safety, and achieve the sustainable development of the enterprise.

News and Information

Learn More
Learn More